Views on primary prevention of cardiovascular disease-an interview study with Swedish GPs

BMC Family Practice

Volumn 11, Issue , 2010, Pages

  Silwer, Louise ^a,b   Wahlström, Rolf ^c,d   Lundborg, Cecilia Stålsby ^a,c  

^a NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^b HALMSTAD UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL COMPETENCE; CLINICAL PRACTICE; COUNSELING; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MALE; METHODOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; STANDARD; SWEDEN;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; COUNSELING; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; QUALITATIVE RESEARCH; SWEDEN;

EID: 77954202681     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-11-44     Document Type: Review

References (34)

1. Patterns of drug use during a 15 year period: data from a Swedish county 1988-2002. L Silwer C Stålsby Lundborg, Pharmacoepidemiol Drug Saf 2005 14 813 20 10.1002/pds.1124 15954078
2. Variations and increase in use of statins across Europe: data from administrative databases. T Walley P Folino-Gallo U Schwabe E van Ganse EuroMedStat group, Brit Med J 2004 328 385 6 10.1136/bmj.328.7436.385 14962875
3. On the variation in conceptions among primary care physicians regarding hypercholesterolemia: a phenomenographic analysis. LO Dahlgren VK Diwan G Tomson R Wahlström, Scand J Prim Health Care 1992 10 316 20 10.3109/ 02813439209014081 1480874
4. Treatment with statins in general medicine: dosage and effectiveness (in French). P Amouyel H Lamarque JL Gayet, Arch Mal Coeur Vaiss 2005 98 1206 11 16435599
5. Evidence for a combined approach to the management of hypertension and dyslipidemia. BJ Ansell, Am J Hypertens 2005 18 1249 57 10.1016/j.amjhyper.2005. 03.740 16245413
6. Drug therapy hand book (Läkemedelsboken). Apoteket AB, Stockholm 2005 [In Swedish]
7. Controversies in hypertension. NM Kaplan LH Opie, Lancet 2006 367 168 76 10.1016/S0140-6736(06)67965-8 16413880
8. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. KM Eriksson CJ Westborg MC Eliasson, Scand J Public Health 2006 34 453 61 10.1080/14034940500489826 16990155
9. Is there a pathology of prevention? The implications of visualizing the invisible in screening programs. L Sachs, Cult Med Psychiatry 1995 19 503 25 10.1007/BF01379400 8838297
10. Medicalisation, limits to medicine, or never enough money to go around? N Freemantle S Hill, Brit Med J 2002 324 864 5 10.1136/bmj.324.7342.864 11950720
11. The public view on cardiovascular risk factors and changes in lifestyle. B Danielsson H Aberg, Scand J Prim Health Care 1995 13 74 80 10.3109/02813439508996739 7777740
12. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. RJ McManus J Mant CF Meulendijks RA Salter HM Pattison AK Roalfe FD Hobbs, Brit Med J 2002 324 459 64 10.1136/bmj.324.7335.459 11859049
13. Perceptions of cardiovascular risk among patients with hypertension or diabetes. BD Frijling CM Lobo, Patient Educ Couns 2004 52 47 53 10.1016/S0738-3991(02)00248-3 14729290
14. Moderately elevated blood pressure. A systematic review. The Swedish council on Technology assessment in health care http://www.sbu.se/upload/ Publikationer/Content0/1/Blodtryck-2004/Hypertoni-vol-1.pdf
15. Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden-individual data from national registers. L Silwer C Stålsby Lundborg M Petzold, Pharmacoepidemiol Drug Saf 2008 17 37 42 10.1002/pds.1515 17987590
16. Ways of experiencing asthma management. Variations among general practitioners in Sweden. CS Lundborg R Wahlstrom G Dall'Alba, Scand J Prim Health Care 1999 17 226 31 10.1080/028134399750002458 10674300
17. On the unit of description in phenomenography. F Marton WY Pong, Higher Education Research and Development 2005 4 335 348 10.1080/07294360500284706 (Pubitemid 43084447)
18. Fenomenografi. H Olsson S Sörensen, Forskningsprocessen-kvalitativa och kvantitativa perspektiv, Stockholm, Liber, 2 2005 106 109
19. Physical activity on prescription. The Swedish National Institute of Public Health http://www.fhi.se/PageFiles/3158/FYSS-08(1).pdf
20. Probability at the bedside: The knowing of chances or the chances of knowing. SN Goodman, Ann Intern Med 1999 130 604 6 10189332
21. Talking about treatment: The language of populations and the language of individuals. JF Steiner, Ann Intern Med 1999 130 618 21 10189345
22. Cholesterol-lowering therapy: what patients expect in return. WW Reed JE Herbers GL Noel, J Gen Inter Med 1993 8 591 6 10.1007/BF02599710
23. Perspectives on prevention: the views of General Practitioners. SJ Williams M Calnan, Sociol Health Illn 1994 16 372 93 10.1111/1467-9566. ep11348775
24. A nurse in preventive work. V Adelswärd L Sachs, Scand J Caring Sci 1996 10 45 52 8715785
25. GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions. J Wens E Vermeire P Van Royen B Sabbe J Denekens, BMC Fam Pract 2005 6 20 10.1186/1471-2296-6-20 15890071
26. Family physician's knowledge, beliefs and self-reported practice patterns regarding hyperlipidemia: A national research network (NRN) survey. CB Eaton JM Galliher PE McBride AJ Bonham JA Kappus J Hickner, J Am Board Fam Med 2006 19 46 53 10.3122/jabfm.19.1.46 16492005
27. From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolemia. K Fairhurst G Huby, Brit Med J 1998 317 1130 4 9784451
28. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. J Kedward L Dakin, Br J Gen Pract 2003 53 684 9 15103875
29. Patients' and physicians' perceptions and experience of hypercholesterolemia: a qualitative study. I Durack-Bown P Giral JF d'Ivernois C Bazin R Chadarevian A Benkritly E Bruckert, Br J Gen Pract 2003 53 851 7 14702904
30. Shared decision-making in primary care: the neglected second half of the consultation. G Elwyn A Edwards P Kinnersley, Br J Gen Pract 1999 49 477 82 10562751
31. Behag og ubehag: følelsers betydning i praktiserende lægers lægemiddelordination [In Danish]. (Comfort and discomfort: The role of emotions in general practitioners' prescribing of medicines). K Henriksen EH Hansen, Ugeskrift for Læger 2005 167 4650 54
32. The threatened self: general practitioners' self-perception in relation to prescribing medicine. K Henriksen EH Hansen, Soc Sci Med 2004 59 47 55 10.1016/j.socscimed.2003.10.004 15087142
33. Förebyggande av aterosklerotisk hjärt-kärlsjukdom- behandlingsrekommendation [In swedish]. (Prevention of atherosclerotic cardiovascular disease-Guidelines). Information från Läkemedelsverket 2006 3 16 31 http://www.lakemedelsverket.se/upload/halso-och-sjukvard/ behandlingsrekommendationer/080313-primarprevention.pdf (Swedish Medical Products Agency)
34. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. I Graham D Atar K Borch-johnsen G Boysen G Burell, et al. Eur Heart J 2007 28 2375 2414 http://www.escardio.org/guidelines-surveys/ esc-guidelines/GuidelinesDocuments/guidelines-CVD-prevention-ES.pdf 10.1093/eurheartj/ehm316 17726041